Shares for the Walgreen Boots alliance dropped this week after quarterly revenues failed to meet analyst estimates, with the company posting a 2.4 percent increase to $29.5 billion, short of the $29.7billion expected.

Shares fell 2.4 percent to $81.55 on Wednesday, with the company said to be bowing to pressure to reduce prices and offer lower drug costs. Indeed, sales of convenience products such as toothpaste, make-up, soap and food declined.

The company is working on remodelling stores with a more attractive cosmetics area in a bid to engage more healthy and active female consumers, which are seen to be the biggest purchasing decision maker within families.

A similar model was adopted by competitor CVS before abandoning the plans.